Study #2024-0491
A prospective, multicenter, open-label, non-randomized, controlled pivotal study to evaluate the safety and effectiveness of ARTIA reconstructive tissue matrix in implant-based two-stage prepectoral breast reconstruction Post-Mastectomy.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The purpose of this study is to evaluate the safety and effectiveness of ARTIA in adult participants undergoing immediate, two-stage, implant-based breast reconstruction post-mastectomy.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Breast Reconstruction
Study phase:
Phase III
Physician name:
Alexander Mericli
Department:
Plastic Surgery
For general questions about clinical trials:
1-855-996-1481
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.